PT  - JOURNAL ARTICLE
AU  - Kember, Rachel L.
AU  - Vickers-Smith, Rachel
AU  - Zhou, Hang
AU  - Xu, Heng
AU  - Dao, Cecilia
AU  - Justice, Amy C.
AU  - Gelernter, Joel
AU  - Vujkovic, Marijana
AU  - Kranzler, Henry R.
TI  - Genetic underpinnings of the transition from alcohol consumption to alcohol use disorder: shared and unique genetic architectures in a cross-ancestry sample
AID  - 10.1101/2021.09.08.21263302
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.09.08.21263302
4099  - http://medrxiv.org/content/early/2021/09/13/2021.09.08.21263302.short
4100  - http://medrxiv.org/content/early/2021/09/13/2021.09.08.21263302.full
AB  - Recent GWAS of alcohol-related traits have uncovered key differences in the underlying genetic architectures of alcohol consumption and alcohol use disorder (AUD), with the two traits having opposite genetic correlations with psychiatric disorders. Understanding the genetic factors that underlie the transition from heavy drinking to AUD has important theoretical and clinical implications. We utilized longitudinal data from the cross-ancestry Million Veteran Program sample to identify 1) novel loci associated with AUD and alcohol consumption [measured by the Alcohol Use Disorders Identification Test-Consumption (AUDIT-C)] and 2) genetic variants with direct effects on AUD not mediated through alcohol consumption. We identified 26 loci associated with AUD, including 5 ancestry-specific and 6 novel loci and 22 loci associated with AUDIT-C, including 3 ancestry-specific and 8 novel loci. In secondary GWAS that excluded individuals who report abstinence, we identify 7 additional loci for AUD and 8 additional loci for AUDIT-C. We demonstrate that, although the heterogeneity of the abstinent group biases the GWAS findings, unique variance between alcohol consumption and disorder remains after the group is excluded. Finally, using mediation analysis, we identified a set of variants with effects on AUD that are not mediated through alcohol consumption. The distinct genetic architectures of alcohol consumption and AUD suggest different biological contributions to the traits. Genetic variants with direct effects on AUD are potentially relevant to understanding the transition from heavy alcohol consumption to AUD and targets for translational prevention and treatment efforts.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by Merit Review Award # I01 BX003341 from the U.S. Department of Veterans Affairs Biomedical Laboratory Research and Development Service; the VISN 4 Mental Illness Research, Education, and Clinical Center; and NIAAA grant K01 AA028292 (to RLK). The views expressed in this article are those of the authors and do not necessarily represent the position or policy of the Department of Veterans Affairs or the United States Government.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Written informed consent was obtained from all MVP study participants. Following consent, Veterans provided a blood sample for DNA extraction and genotyping, many completed surveys about health and lifestyle, and all allowed access to their EHR for research purposes. The MVP received approval from the Central Veterans Affairs Institutional Review Board (IRB) and site-specific IRBs. All relevant ethical regulations for work with human subjects were followed in the conduct of the study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSummary statistics from the GWAS will be available following publication through dbGaP at accession no. phs001672.v3.p 1